Reactive [astrocytes](/entities/astrocytes), particularly the A1 phenotype, have emerged as critical contributors to neurodegenerative disease progression. Originally characterized by Liddelow et al. in 2017, A1 astrocytes are induced by microglial release of IL-1α, TNF, and C1q, and they acquire a neurotoxic phenotype that can harm [neurons](/entities/neurons) and oligodendrocytes. Understanding A1 astrocytes is essential for developing therapeutic strategies targeting neuroinflammation in Alzheimer's disease, Parkinson's disease, ALS, and other neurodegenerative conditions. [@liddelow2017]
Reactive [astrocytes](/entities/astrocytes), particularly the A1 phenotype, have emerged as critical contributors to neurodegenerative disease progression. Originally characterized by Liddelow et al. in 2017, A1 astrocytes are induced by microglial release of IL-1α, TNF, and C1q, and they acquire a neurotoxic phenotype that can harm [neurons](/entities/neurons) and oligodendrocytes. Understanding A1 astrocytes is essential for developing therapeutic strategies targeting neuroinflammation in Alzheimer's disease, Parkinson's disease, ALS, and other neurodegenerative conditions. [@liddelow2017]
Overview
Mermaid diagram (expand to render)
Astrocytes are the most abundant glial cell type in the human brain, performing essential functions including: [@yun2018]
Metabolic support: Providing lactate and nutrients to neurons
Ion homeostasis: Regulating extracellular potassium and pH
Synaptic support: Releasing gliotransmitters
[Blood-brain barrier](/entities/blood-brain-barrier) maintenance: Coordinating with endothelial cells
In disease states, astrocytes become "reactive" and undergo morphological and molecular changes. The A1 subtype represents a particularly harmful reactive state associated with neurodegeneration. [@guttenplan2020]
A1 Astrocyte Characteristics
Molecular Signature
A1 astrocytes upregulate a distinct set of genes: [@sofroniew2020]
Morphological Changes
Hypertrophy: Increased soma size and process thickness
The study of Reactive Astrocytes A1 Phenotype In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Pathway Diagram
The following diagram shows the key molecular relationships involving Reactive Astrocytes A1 Phenotype in Neurodegeneration discovered through SciDEX knowledge graph analysis: